EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells.
about
The MST/Hippo Pathway and Cell Death: A Non-Canonical AffairThe ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cellsEarly growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brainETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolismEarly growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3.Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma.Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells.Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor modelEGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells.Early growth response 1 regulates glucose deprivation-induced necrosis.Silencing Egr1 Attenuates Radiation-Induced Apoptosis in Normal Tissues while Killing Cancer Cells and Delaying Tumor Growth.Effect of YAP1 silencing on esophageal cancer.A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cellsGastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK.Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.Lipopolysaccharide Induces Human Pulmonary Micro-Vascular Endothelial Apoptosis via the YAP Signaling Pathway.Age-associated up-regulation of EGR1 promotes granulosa cell apoptosis during follicle atresia in mice through the NF-κB pathway.Is EGR1 a potential target for prostate cancer therapy?Enthalpic factors override the polyelectrolyte effect in the binding of EGR1 transcription factor to DNA.Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.Role of promoter DNA sequence variations on the binding of EGR1 transcription factor.The anticancer effects of resveratrol: modulation of transcription factors.RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cellsExpression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.2'-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells.Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy.DNA binding partners of YAP/TAZ.Immediate-Early Promoter-Driven Transgenic Reporter System for Neuroethological Research in a Hemimetabolous Insect
P2860
Q26744308-CE8D74D7-B8E6-45ED-A553-E877F1180CCEQ28390612-A45EA152-A240-4427-85EA-237814A4F13FQ28578526-8E970AA6-411D-4454-A607-2CABEAA4F652Q30008747-16D33DB5-8766-4D06-838D-E8B371B85D6BQ33720340-8BD9D644-7E84-4DD1-815E-089F0AF480D6Q33723716-3FFFAC97-D938-414C-9288-9FF771583022Q34157472-C1DC893E-EFCA-4263-81B8-4DCA9C0568B4Q34490491-3A481C0A-9C3C-41A1-AB07-54CD05FCC684Q34762351-D0AD06EA-AA8E-40B1-90E5-CC2267F975F2Q34986449-62E1E651-0CE6-4B2C-A80C-2966156B40ECQ35213033-02F2FF01-E79F-4EB8-A3CC-BB5ABFE71843Q35979171-213893DB-6D2F-46C8-B2C5-9D51B526C6BCQ36078600-DFCFF06B-7BFB-48E2-B099-CF7A7C26EEF4Q36642750-1707BBDE-2304-4231-B030-F2CFFF850717Q36837385-1AFC3D10-02AB-45CE-AC76-92FCC3F3ED71Q36955645-502F893E-7AB5-4D8F-B947-B4D9B7F634BFQ37061016-65289B69-819F-49A3-A15B-F0B46478A6C8Q37179471-3BDAF205-3FD2-4311-99F9-C32524E0EF46Q37225620-5E208D6F-5AAD-4DD3-B8EE-51944A511C7BQ37348630-8D7960CB-60F2-4286-83A4-1676290AD919Q37409398-D489AC43-5BF1-4D8D-860A-36441F6F91AEQ37418513-EBF32962-B707-4A28-B4C5-7154423BBD45Q37497572-6DB43771-75DB-4131-BAD2-DDD7EB1A91C7Q37706969-3D416F31-E5BF-4E04-8C47-8F038139E853Q37735427-D6F3D773-3206-498A-AC2A-3B92433721EEQ38000616-7A504DB8-20FD-48E4-B79A-1F94FA892945Q38009322-147119A5-C587-4616-82AD-2CC6F002ED83Q38858430-5F8EB8C7-AB43-4430-92F0-B56DECEAEC86Q39261184-0E3B8CF1-C824-443D-A5BF-A2F044B4E519Q39339508-95F70667-550D-4D1D-B06A-EFDF6CDCE312Q39589853-D0965A22-A397-4438-9F5E-1A8B89D79770Q41084272-0D47C51C-D2F6-473B-8257-E9EC2CB0EE8CQ49797899-11B7F511-8D5C-444B-ADF1-5F576BFE0D7CQ58764557-DB2BE9FF-808B-4537-8E5D-1C6F03A6F60A
P2860
EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@en
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@nl
type
label
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@en
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@nl
prefLabel
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@en
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@nl
P2093
P356
P1433
P1476
EGR-1 forms a complex with YAP ...... ated prostate carcinoma cells.
@en
P2093
J Prichard
M M Shareef
M Mohiuddin
M T Bedford
M Zagurovskaya
P2888
P304
P356
10.1038/ONC.2008.461
P407
P577
2009-01-12T00:00:00Z